These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29705220)

  • 1. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
    Chin KM; Gomberg-Maitland M; Channick RN; Cuttica MJ; Fischer A; Frantz RP; Hunsche E; Kleinman L; McConnell JW; McLaughlin VV; Miller CE; Zamanian RT; Zastrow MS; Badesch DB
    Chest; 2018 Oct; 154(4):848-861. PubMed ID: 29705220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH.
    McCollister D; Shaffer S; Badesch DB; Filusch A; Hunsche E; Schüler R; Wiklund I; Peacock A;
    Respir Res; 2016 Jun; 17(1):72. PubMed ID: 27301413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients.
    Bonner N; Abetz L; Meunier J; Sikirica M; Mathai SC
    Health Qual Life Outcomes; 2013 Oct; 11():161. PubMed ID: 24088389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Arterial Hypertension-Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting.
    Frantz RP; Chin KM; Zhao C; Flynn M; Badesch D
    Pulm Circ; 2020; 10(2):2045894020923957. PubMed ID: 32489644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural adaptation of the Cambridge Pulmonary Hypertension Outcome Review for use in patients with pulmonary hypertension in Colombia.
    Villaquirán C; Moreno S; Dueñas R; Acuña P; Lutz JR; Wilburn J; Heaney A
    J Bras Pneumol; 2019 Jul; 45(6):e20180332. PubMed ID: 31365733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).
    Gelhorn HL; Roberts LJ; Khandelwal N; Revicki DA; DeRogatis LR; Dobs A; Hepp Z; Miller MG
    J Sex Med; 2017 Aug; 14(8):1046-1058. PubMed ID: 28760247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary.
    Kawata AK; Hsieh R; Bender R; Shaffer S; Revicki DA; Bayliss M; Buse DC; Desai P; Sapra S; Ortmeier B; Hareendran A
    Headache; 2017 Oct; 57(9):1385-1398. PubMed ID: 28857154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire.
    Reis A; Twiss J; Vicente M; Gonçalves F; Carvalho L; Meireles J; Melo A; McKenna SP; Almeida L
    Health Qual Life Outcomes; 2016 Jul; 14(1):110. PubMed ID: 27460644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ).
    Kawata AK; Hareendran A; Shaffer S; Mannix S; Thach A; Desai P; Mikol DD; Ortmeier B; Bayliss M; Buse DC
    Headache; 2019 Sep; 59(8):1253-1269. PubMed ID: 31168803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
    Hareendran A; Make BJ; Zaiser E; Garcia Gil E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1633-1645. PubMed ID: 29849455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument.
    Mocarski M; Zaiser E; Trundell D; Make BJ; Hareendran A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():475-87. PubMed ID: 25834415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.
    Gelhorn HL; Dashiell-Aje E; Miller MG; DeRogatis LR; Dobs A; Seftel AD; Althof SE; Brod M; Revicki DA
    J Sex Med; 2016 Nov; 13(11):1737-1749. PubMed ID: 27692845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Mehta S; Sastry BKS; Souza R; Torbicki A; Ghofrani HA; Channick RN; Delcroix M; Pulido T; Simonneau G; Wlodarczyk J; Rubin LJ; Jansa P; Hunsche E; Galiè N; Perchenet L; Sitbon O
    Chest; 2017 Jan; 151(1):106-118. PubMed ID: 27671974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in ambulatory pulmonary arterial hypertension in connective tissue diseases and its relationship with risk stratification.
    Shi Y; Meng Y; Dong X; Liu Y; Liu Y; Lai J; Tian Z; Zhao J; Peng J; Wang Q; Li M; Zeng X
    Pulm Circ; 2021; 11(3):20458940211029899. PubMed ID: 34290858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcome domains for the esophageal CONDUIT report card: a prospective trial to establish domains.
    Lee MK; Yost KJ; Pierson KE; Blackmon SH
    Health Qual Life Outcomes; 2018 Oct; 16(1):197. PubMed ID: 30305083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact on caregivers of patients with schizophrenia: psychometric validation of the Schizophrenia Caregiver Questionnaire (SCQ).
    Rofail D; Regnault A; le Scouiller S; Lambert J; Zarit SH
    BMC Psychiatry; 2016 Jul; 16():245. PubMed ID: 27431493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
    Wright DD; Paty J; Turner-Bowker DM; Bradbury A
    Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.